[Pathogenesis and treatment of nonallergic drug-hypersesitivity (focus on ace inhibitor and NSAIDs)].
Taniguchi
Masami
M
National Hospital Organization Sagamihara Hospital Clinical Research Center. m-taniguchi@sagamihara-hosp.gr.jp
D000799:Angioedema / Q000209:etiology / Q000628:therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001920:Bradykinin; D003545:Cysteine; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000628:therapy*; D004837:Epinephrine / Q000627:therapeutic use*; D005440:Fluid Therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006636:Histamine Release; D006801:Humans; D007073:Immunoglobulin E; D015289:Leukotrienes; D008407:Mast Cells
D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D015289:Leukotrienes; C112381:cysteinyl-leukotriene; D007073:Immunoglobulin E; D003545:Cysteine; D001920:Bradykinin; D004837:Epinephrine